GMM Pfaudler (505255) Q4 04/05 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 04/05 earnings summary
2 Nov, 2026Executive summary
FY05 sales and other income rose 29% YoY to Rs823.8m; PBT increased 56% to Rs115.3m and PAT reached Rs76.2m.
Performance gains were attributed to market-share initiatives and cost control, while demand was strongest in pharmaceutical, fine chemical and agrochemical markets.
Financial highlights
Income from operations was Rs805.4m vs Rs589.7m; net sales were Rs803.1m vs Rs588.1m.
PBT was Rs115.3m vs Rs73.8m; PAT was Rs76.2m vs Rs62.1m, before Rs0.1m of prior-year tax adjustments.
Operating cash flow was Rs28.9m vs Rs40.3m; cash and cash equivalents ended FY05 at Rs10.7m.
Outlook and guidance
Order backlog was Rs437m at end-June 2005 vs Rs382m a year earlier, reflecting sales and marketing initiatives and product innovation.
Continued strong product and service demand supported the outlook; equipment pricing remained under pressure from intense competition.
Latest events from GMM Pfaudler
- Record orders and backlog support growth as European losses weigh on reported margins.505255
Q2 26/27 - Sales and profits declined as exports, reglassing and new products became growth priorities.505255Q4 96/97
- Recession drove sharp FY98 declines as exports and cost cuts became the recovery levers.505255Q4 97/98
- Higher sales and record orders were offset by lower profits and depressed pricing.505255Q4 98/99
- Revenue grew, profit weakened, while Q1 sales and backlog rebounded.505255Q4 99/00
- Export growth lifted sales, but recession and margin pressure cut pre-tax profit.505255Q4 00/01
- Sales and profit fell, but backlog grew as product and technology investments advanced.505255Q4 01/02
- Profit more than tripled as backlog grew, despite pricing, power and investment risks.505255Q4 02/03
- Profit more than doubled as orders strengthened, despite pricing and power headwinds.505255Q4 03/04